Showing results (1-10 of 418) with videos related to
Sort By:
Pageof 42
Drugs|February 17, 1998
Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospectsH Hebart, L Kanz, G Jahn, et al.Journal of Cancer Research and Clinical Oncology|July 24, 2002
Correlations between hematopoietic progenitor cell counts as measured by Sysmex and CD34+ cell harvest yields following mobilization with different regimensW Vogel, H G Kopp, L Kanz, et al.Zeitschrift Fur Rheumatologie|September 29, 1999
[Interferon-alpha-associated polyarthritis. Possible induction of seropositive rheumatoid arthritis by interferon-alpha: two case reports and review of the literature]I Kötter, C A Müller, H Einsele, et al.Bone Marrow Transplantation|September 18, 2003
Successful haematopoietic stem cell transplantation from a matched unrelated donor following three graft failures from HLA-mismatched related donorsA Wiesmann, P Bader, C Faul, et al.Bone Marrow Transplantation|January 22, 2000
Successful treatment of human herpesvirus-6 encephalitis after bone marrow transplantationW Bethge, R Beck, G Jahn, et al.Bone Marrow Transplantation|October 3, 1998
Avascular necrosis of bone following allogeneic stem cell transplantation: MR screening and therapeutic optionsA Wiesmann, P Pereira, P Böhm, et al.Bone Marrow Transplantation|April 10, 1999
Treatment of acute graft-versus-host disease with PUVA (psoralen and ultraviolet irradiation): results of a pilot studyA Wiesmann, A Weller, G Lischka, et al.Bone Marrow Transplantation|August 28, 2003
Severe acute graft-versus-host disease after T-cell depleted allogeneic stem cell graft from a second donor caused by persisting T-cells from the first donorA Wiesmann, P Bader, M Bamberg, et al.Oncology Reports|May 20, 2011
Malignant fibrous histiocytoma of bone - Review of thirteen casesJ Hartmann, I Thiel, H Schmoll, et al.Der Radiologe|September 28, 2000
[The MR characterization of the composition of the hematopoietic bone marrow. The findings in generalized neoplasms and the monitoring of therapy]J Machann, P L Pereira, H Einsele, et al.Pageof 42